Author:
Malfatti Michael A.,Kuhn Edward A.,Murugesh Deepa K.,Mendez Melanie E.,Hum Nicholas,Thissen James B.,Jaing Crystal J.,Loots Gabriela G.
Abstract
AbstractThe gut microbiota is a vast and diverse microbial community that has co-evolved with its host to perform a variety of essential functions involved in the utilization of nutrients and the processing of xenobiotics. Shifts in the composition of gut microbiota can disturb the balance of organisms which can influence the biodisposition of orally administered drugs. To determine how changes in the gut microbiome can alter drug disposition, the pharmacokinetics (PK), and biodistribution of acetaminophen were assessed in C57Bl/6 mice after treatment with the antibiotics ciprofloxacin, amoxicillin, or a cocktail of ampicillin/neomycin. Altered PK, and excretion profiles of acetaminophen were observed in antibiotic exposed animals. Plasma Cmax was significantly decreased in antibiotic treated animals suggesting decreased bioavailability. Urinary metabolite profiles revealed decreases in acetaminophen-sulfate metabolite levels in both the amoxicillin and ampicillin/neomycin treated animals. The ratio between urinary and fecal excretion was also altered in antibiotic treated animals. Analysis of gut microbe composition revealed that changes in microbe content in antibiotic treated animals was associated with changes in acetaminophen biodisposition. These results suggest that exposure to amoxicillin or ampicillin/neomycin can alter the biodisposition of acetaminophen and that these alterations could be due to changes in gut microbiome composition.
Funder
DOE | LDRD | Lawrence Livermore National Laboratory
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Clayton, T. A., Baker, D., Lindon, J. C., Everett, J. R. & Nicholson, J. K. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc. Natl. Acad. Sci. USA 106, 14728–14733 (2009).
2. Zheng, X. et al. The footprints of gut microbial_mammalian co-metabolism. J. Proteome Res. 10, 5512–5522 (2011).
3. Swanson, H. I. Drug metabolism by the host and gut Microbiota: A partnership or rivalry? Drug. Metab. Dispos. 43, 1499–1504 (2015).
4. Lindenbaum, J., Tse-Eng, D., Butler, V. P. Jr. & Rund, D. G. Urinary excretion of reduced metabolites of digoxin. Am. J. Med. 71, 67–74 (1981).
5. Dobkin, J. F., Saha, J. R., Butler, V. P. Jr., Neu, H. C. & Lindenbaum, J. Inactivation of digoxin by Eubacterium lentum, an anaerobe of the human gut flora. Trans. Assoc. Am. Physicians 95, 22–29 (1982).
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献